Analysis on Impact of COVID-19-Technavio Evaluates the Impact of Increase in Research Funding and Grants and Rise in M&A Activities in its Biosimulation Market Analysis

Technavio has announced its latest market research report titled Global Biosimulation Market 2020-2024 (Graphic: Business Wire)

LONDON--()--The biosimulation market is likely to experience steady growth because of an increase in research funding and grants and a rise in M&A activities. Rising at a CAGR of almost 13%, the market is estimated to have an incremental growth of USD 1.49 billion by 2024. Download Free Sample Report

A Technavio analyst says, "The global biosimulation market will not be majorly impacted by the spread of COVID-19. However, the market outlook might change if the containment efforts go beyond Q2 2020."

Technavio’s recent analysis of the biosimulation market, includes a detailed examination of its revenue forecasts, including market drivers and challenges, key market participants, and growth opportunities. The study segments the markets in North America, Europe, Asia, and ROW, geographically. The North America region is expected to have a market share of 43%. This growth can be attributed to the strong presence of FDA-approved manufacturing facilities.

For further information on this analysis, please visit: https://www.technavio.com/report/biosimulation-market-industry-analysis

Misconceptions about computer system validation and the imitations of CROs might hamper the market growth. However, the use of mathematical modeling and simulation to improve generic drugs will positively influence the growth of the global biosimulation market.

Technavio’s analysis of the biosimulation market also includes:

  • CAGR of the market during the forecast period 2020-2024
  • Detailed information on factors that will drive the biosimulation market growth during the next five years
  • Precise estimation of the biosimulation market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the biosimulation market industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape
  • Comprehensive details of factors that will challenge the growth of biosimulation market vendors

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com

 

Release Summary

The biosimulation market size has the potential to grow by USD 1.49 bn during 2020-2024

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com